Literature DB >> 28271414

Pediatric follicular lymphoma in Japan.

Ryoji Kobayashi1,2, Fumiko Tanaka3, Atsuko Nakazawa4, Jun-Ichi Ueyama5, Shosuke Sunami6, Tetsuo Mitsui7, Yuhki Koga8, Takeshi Mori9, Tomoo Osumi10, Reiji Fukano11, Kentaro Ohki12, Masahiro Sekimizu13, Naoto Fujita14, Michi Kamei15, Tetsuya Mori16.   

Abstract

Follicular lymphoma (FL) is quite rare in children. There have been only two major reports on pediatric FL. The present retrospective study on pediatric FL in Japan, including FL with diffuse large B cell lymphoma (DLBCL), analyzed data from 1991 to 2014. Twenty-two patients with pediatric FL were analyzed. Sixteen patients were boys and six were girls. Median age of onset was 9 years (range 4-17 years). In 11 patients, DLBCL co-existed with FL. The initial lesions involved cervical lesions in 16 patients, and the abdomen in six. With regard to stage of disease at diagnosis, 17 patients were at stage I or II, four were at stage III, and one was at stage IV. Chemotherapy was administered in 18 patients, and only resection was performed in four patients. Mature B lymphoma regimens were selected for 17 patients who received chemotherapy. Although two patients relapsed, all patients are currently alive and disease free. The median follow-up period was 54.5 months (range 6-126 months). Patients having FL with DLBCL were younger compared with those having FL, and this disease was more frequently observed in female patients. Our data revealed that FL in Japanese children is a tumor with good prognosis, as in reports from the United States and Europe.

Entities:  

Keywords:  Childhood; Follicular lymphoma; Pediatric follicular lymphoma

Mesh:

Year:  2017        PMID: 28271414     DOI: 10.1007/s12185-017-2209-1

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  11 in total

1.  Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients.

Authors:  Y Bastion; C Sebban; F Berger; P Felman; G Salles; C Dumontet; P A Bryon; B Coiffier
Journal:  J Clin Oncol       Date:  1997-04       Impact factor: 44.544

Review 2.  Treatment of pediatric lymphoma in Japan: Current status and plans for the future.

Authors:  Ryoji Kobayashi; Shosuke Sunami; Tetsuo Mitsui; Atsuko Nakazawa; Yuhki Koga; Takeshi Mori; Fumiko Tanaka; Jun-ichi Ueyama; Tomoo Osumi; Reiji Fukano; Kentaro Ohki; Masahiro Sekimizu; Tetsuya Mori
Journal:  Pediatr Int       Date:  2015-08       Impact factor: 1.524

3.  Incidence of transformation to aggressive lymphoma in limited-stage follicular lymphoma treated with radiotherapy.

Authors:  P Bains; A Al Tourah; B A Campbell; T Pickles; R D Gascoyne; J M Connors; K J Savage
Journal:  Ann Oncol       Date:  2012-10-03       Impact factor: 32.976

4.  Investigation of the freely available easy-to-use software 'EZR' for medical statistics.

Authors:  Y Kanda
Journal:  Bone Marrow Transplant       Date:  2012-12-03       Impact factor: 5.483

5.  Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.

Authors:  Massimo Federico; Monica Bellei; Luigi Marcheselli; Stefano Luminari; Armando Lopez-Guillermo; Umberto Vitolo; Barbara Pro; Stefano Pileri; Alessandro Pulsoni; Pierre Soubeyran; Sergio Cortelazzo; Giovanni Martinelli; Maurizio Martelli; Luigi Rigacci; Luca Arcaini; Francesco Di Raimondo; Francesco Merli; Elena Sabattini; Peter McLaughlin; Philippe Solal-Céligny
Journal:  J Clin Oncol       Date:  2009-08-03       Impact factor: 44.544

6.  Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma.

Authors:  Abdulwahab J Al-Tourah; Karamjit K Gill; Mukesh Chhanabhai; Paul J Hoskins; Richard J Klasa; Kerry J Savage; Laurie H Sehn; Tamara N Shenkier; Randy D Gascoyne; Joseph M Connors
Journal:  J Clin Oncol       Date:  2008-10-06       Impact factor: 44.544

7.  Pediatric follicular lymphoma--a clinico-pathological study of a population-based series of patients treated within the Non-Hodgkin's Lymphoma--Berlin-Frankfurt-Munster (NHL-BFM) multicenter trials.

Authors:  Ilske Oschlies; Itziar Salaverria; Friederike Mahn; Andrea Meinhardt; Martin Zimmermann; Wilhelm Woessmann; Birgit Burkhardt; Stefan Gesk; Matthias Krams; Alfred Reiter; Reiner Siebert; Wolfram Klapper
Journal:  Haematologica       Date:  2009-08-13       Impact factor: 9.941

8.  Long-term survival after histologic transformation of low-grade follicular lymphoma.

Authors:  A R Yuen; O W Kamel; J Halpern; S J Horning
Journal:  J Clin Oncol       Date:  1995-07       Impact factor: 44.544

9.  Children and adolescents with follicular lymphoma have an excellent prognosis with either limited chemotherapy or with a "Watch and wait" strategy after complete resection.

Authors:  Andishe Attarbaschi; Auke Beishuizen; Georg Mann; Angelo Rosolen; Tetsuya Mori; Anne Uyttebroeck; Felix Niggli; Monika Csoka; Zdenka Krenova; Karin Mellgren; Edita Kabickova; Alan Ks Chiang; Alfred Reiter; Denise Williams; Birgit Burkhardt
Journal:  Ann Hematol       Date:  2013-05-12       Impact factor: 3.673

10.  Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy.

Authors:  Ranjana Advani; Saul A Rosenberg; Sandra J Horning
Journal:  J Clin Oncol       Date:  2004-03-15       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.